VCYT
Veracyte, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones -21.1% ·
nuevas posiciones netas +7.1%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +4 | 67.58M | $3.96B | +10 | −6 |
| Q1 2026 | 118 | +6 | 67.37M | $2.17B | +10 | −4 |
| Q4 2025 | 112 | 0 | 69.04M | $2.91B | +2 | −2 |
| Q3 2025 | 18 | -2 | 46.98M | $1.61B | — | −3 |
| Q2 2025 | 18 | 0 | 39.06M | $1.06B | +1 | −1 |
| Q1 2025 | 15 | -1 | 15.53M | $460.45M | — | −1 |
| Q4 2024 | 16 | +1 | 17.75M | $702.81M | +1 | — |
| Q3 2024 | 14 | +1 | 14.22M | $484.20M | +3 | −2 |
| Q2 2024 | 13 | — | 18.04M | $390.85M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 4.92M | -27.7% | $167.50M | 1.5% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 1.84M | +1.0% | $62.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 1.84M | +1.0% | $62.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 877.76K | -1.4% | $29.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 594.30K | +41.2% | $20.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 500.37K | +950.3% | $17.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 500.37K | +950.3% | $17.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 335.51K | +422.4% | $11.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 271.25K | Nuevo | $9.23M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 190.29K | +225.8% | $6.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 190.29K | +225.8% | $6.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 190.29K | +225.8% | $6.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Norges Bank ✦ (pasivo) | 187.96K | +20.2% | $6.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 110.09K | Nuevo | $3.75M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 95.03K | Nuevo | $3.23M | 0.0% | New | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 46.60K | +4.2% | $1.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 16.51K | +9.6% | $561,932 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Arrowstreet Capital | $9.23M | 0.0% |
| Marshall Wace | $3.75M | 0.0% |
| D. E. Shaw & Co. | $3.23M | 0.0% |
Posición cerrada
| Point72 Asset Management | $12.28M | era 0.0% |
| Duquesne Family Office | $5.63M | era 0.2% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 333 tenedores, 87.61M acciones, $2.75B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.